Login / Signup

The LIFT trial: study protocol for a double-blind, randomised, placebo-controlled trial of K+-binder Lokelma for maximisation of RAAS inhibition in CKD patients with heart failure.

Daniel MurphyIrina Chis SterJuan-Carlos KaskiLisa AndersonDebasish Banerjee
Published in: BMC nephrology (2021)
EudraCT number 2020-002946-18. Registered on 08 June 2020. Online record pending.
Keyphrases
  • study protocol
  • double blind
  • phase iii
  • clinical trial
  • phase ii
  • placebo controlled
  • open label
  • randomized controlled trial
  • chronic kidney disease
  • social media
  • health information
  • healthcare